Genzyme

NanoString raises $20 million in Series D financing

Monday, November 7, 2011 09:52 AM

NanoString Technologies, a privately held provider of life science tools for translational research and developer of molecular diagnostics, has closed $20 million in a Series D round of equity financing. New investors include GE, BioMed Ventures and Henri Termeer, former chairman and CEO of Genzyme. All previous venture investors in NanoString also participated in the financing, including Clarus Ventures, Draper Fisher Jurvetson and OVP Venture Partners.

More... »

Sanofi restructues cutting sales jobs

Wednesday, November 2, 2011 01:43 PM

French drugmaker Sanofi has reported it is reorganizing research operations in the U.S. and planning to trim its sales force for the second time in barely a year as it aims to boost efficiency, according to the Associated Press.

More... »

Sanofi names Meeker CEO of Genzyme

Monday, October 24, 2011 01:18 PM

Sanofi has named David Meeker as chief executive officer of Genzyme, a Sanofi company, effective November 1, 2011. He will report to Christopher A. Viehbacher, chief executive officer of Sanofi, and will join the group management committee. Viehbacher will retain the position of chairman, Genzyme.

More... »

Proteostasis names Enyedy CEO

Thursday, October 20, 2011 10:27 AM

Proteostasis Therapeutics has named Mark J. Enyedy chief executive officer. Enyedy joins Proteostasis after serving 15 years at Genzyme, most recently as president of the transplant, oncology and multiple sclerosis divisions. Enyedy has also been elected to the Proteostasis board of directors.

More... »

Oncobiologics names Canute to board of directors

Wednesday, October 12, 2011 11:31 AM

Oncobiologics has named Scott Canute to its board of directors.

More... »

Former Genzyme chief donates $10 million to MGH

Wednesday, September 14, 2011 11:00 AM

Retired biotechnology executive Henri A. Termeer, who built Genzyme into the largest US company specializing in drugs to treat rare genetic disorders, is donating $10 million to Massachusetts General Hospital to establish it as a world leader in personalized medicine, according to the Boston Globe.

More... »

Roche names president of Ventana Medical Systems

Monday, August 1, 2011 12:09 PM

Ventana Medical Systems, a member of the Roche Group, has named Mara Aspinall president. Aspinall will begin her new role at Ventana in September 2011.

More... »

Venture capital funding for biotech soars 46%

Wednesday, July 20, 2011 01:52 PM

Venture capital funding in biotechnology companies jumped 46% in the second quarter, as investors looked to replenish their portfolios after an increase in acquisitions and initial public offerings, according to Bloomberg News.

More... »

Sanofi: Genzyme unit may be smaller

Thursday, June 2, 2011 11:16 AM

Sanofi has told employees of Cambridge, Mass.-based Genzyme, the biotech Sanofi acquired in April, that they will have a new reporting structure within the parent company, according to The Boston Globe.

More... »

Aveo Pharmaceuticals appoints Henri Termeer to board

Tuesday, April 12, 2011 12:33 PM

Cambridge, Mass.-based Aveo Pharmaceuticals will the appoint Henri A. Termeer, outgoing chairman, president and chief executive officer of Genzyme, to its board of directors.

More... »